中文名称 | (1′R,6R,6aR,7R,13S,14S,16R)-5-(乙酰氧基)-3′,4′,6,6a,7,13,14,16-八氢-6′,8,14-三羟基-7′,9-二甲氧基-4,10,23-三甲基螺[6,16-(环硫基丙氧基甲桥)-7,13-亚氨基-12H-1,3-二氧杂环戊并[7,8]异喹啉并[3,2-b][3]苯并氮杂辛环-20,1′(2′H)-异喹啉]-19-酮;他比特啶 | 曲贝替定 |
---|---|
英文名称 | (1′R,6R,6aR,7R,13S,14S,16R)-5-(Acetyloxy)-3′,4′,6,6a,7,13,14,16-octahydro-6′,8,14-trihydroxy-7′,9-dimethoxy-4,10,23-trimethylspiro[6,16-(epithiopropanoxymethano)-7,13-imino-12H-1,3-dioxolo[7,8]isoquino[3,2-b][3]benzazocine-20,1′(2′H)-isoquinolin]-19-one;Trabectedin (Synonyms: Ecteinascidin 743; ET-743) |
CAS号 | 114899-77-3 |
分子式 | C39H43N3O11S |
分子量 | 761.84 |
外观 | White to light yellow powder |
储存条件 | -20°C, protect from light, stored under nitrogen |
Trabectedin (Ecteinascidin 743; ET-743) is a tetrahydroisoquinoline alkaloid with potent antitumor activity. Trabectedin binds to the minor groove of DNA, blocks transcription of stress-induced proteins, induces DNA backbone cleavage and cancer cells apoptosis, and increases the generation of ROS in MCF-7 and MDA-MB-453 cells. Trabectedin has the potential for soft tissue sarcoma and ovarian cancer research.
© 2020-2024 凯立德生物医药技术(上海)有限公司 版权所有
沪ICP备15046197号-3
沪公网安备31011502007856号
Designed by Kuanersoft